Phibro Animal Health | PAHC - Attività Correnti





Attività Correnti Cambiamento Data
Align Technology USD 2.66B 7.62M 2026-06
ANI Pharmaceuticals USD 825.43M 78.35M 2026-06
Aurora Cannabis CAD 397.45M 48.38M 2026-03
Bristol-Myers Squibb USD 28.58B 1.37B 2026-06
Canopy Growth CAD 529.47M 4.8M 2026-03
Corcept Therapeutics USD 439.68M 13.64M 2026-06
Eli Lilly USD 64.67B 9.84B 2026-06
Henry Schein USD 4.6B 104M 2026-06
Idexx Laboratories USD 1.51B 55.41M 2026-06
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Merck USD 36.68B 1.66B 2026-06
Nektar Therapeutics USD 589.04M 322.77M 2026-03
Pacira USD 615.21M 100.25M 2026-06
Phibro Animal Health USD 894.07M 31.88M 2026-03
Prestige Brands USD 496.81M 65.33M 2026-06
Supernus Pharmaceuticals USD 723.5M 8.08M 2026-06
Zoetis USD 6.36B 118M 2026-06